One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Applications of Microarray Platforms in Modern Biological ResearchApril 2, 2026Microarray platforms are essential tools in genomics and molecular biology, providing an efficient and high-throughput method for simultaneously measuring the expression of thousands of genes or detec...view
Exploring the Benefits of Genome Sequencing ServicesJune 26, 2023Genome sequencing services have revolutionized the field of genetics and healthcare by providing valuable insights into our genetic makeup. With advancements in technology, it is now possible to decod...view
Decoding Genomic Medicine: The Power of Clinical WES in Patient CareJanuary 4, 2024In recent years, genomic medicine has revolutionized the way healthcare professionals diagnose and treat various diseases. A key component of this approach is Clinical WES (Whole Exome Sequencing), wh...view